Raphael Deferiere
Chief Accounting Officer · Centessa Pharmaceuticals plc
Individual
- 2026
- Jun 24, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Raphael Deferiere files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Karen M. Anderson - $9.65M in CNTA purchases and sales in the last 12 months
- Gregory M. Weinhoff - $2.65M in CNTA purchases and sales in the last 12 months
- Tia L. Bush - $2.16M in CNTA purchases and sales in the last 12 months
- Iqbal J. Hussain - $1.17M in CNTA purchases and sales in the last 12 months
- Mario Alberto Accardi - $200K in CNTA purchases and sales in the last 12 months
- Medicxi Ventures Management (Jersey) Ltd - CNTA
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Raphael Deferiere?
Raphael Deferiere is a corporate insider, tracked as Chief Accounting Officer of Centessa Pharmaceuticals plc (CNTA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Raphael Deferiere last file a Form 4?
The most recent primary Form 4 on record is dated 24 June 2026, one of 2 filings going back to 2026.
